LADENBURG THALMANN FINANCIAL SERVICES INC. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 80 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$37,000
+270.0%
1,8500.0%0.00%
Q3 2019$10,000
-16.7%
1,8500.0%0.00%
Q2 2019$12,000
-20.0%
1,850
-19.6%
0.00%
Q1 2019$15,0000.0%2,300
+4.5%
0.00%
Q4 2018$15,000
+200.0%
2,200
+214.3%
0.00%
Q3 2018$5,000
+25.0%
7000.0%0.00%
Q2 2018$4,0000.0%7000.0%0.00%
Q1 2018$4,000
+33.3%
7000.0%0.00%
Q4 2017$3,000
-25.0%
7000.0%0.00%
Q3 2017$4,000
-69.2%
700
-68.2%
0.00%
Q2 2017$13,000
-38.1%
2,200
-24.1%
0.00%
Q1 2017$21,000
+950.0%
2,900
+190.0%
0.00%
Q4 2016$2,0001,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders